Consequences of Shb and c-Abl interactions for cell death in response to various stress stimuli

Experimental Cell Research

Volumn 313, Issue 2, 2007, Pages 284-291

  Hägerkvist, Robert ^a   Mokhtari, Dariush ^a   Lindholm, Cecilia ^a   Farnebo, Filip ^b   Mostoslavsky, Gustavo ^c   Mulligan, Richard C ^c   Welsh, Nils ^a   Welsh, Michael ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Apoptosis; c Abl; ER stress; SH2 domain; Shb; Tyrosine kinase

Indexed keywords

ABELSON KINASE; ADAPTOR PROTEIN; CISPLATIN; DNA; HYDROGEN PEROXIDE; IMATINIB; PROTEIN SH2; PROTEIN SHB; TUNICAMYCIN; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DEATH; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENDOPLASMIC RETICULUM; ENZYME ACTIVITY; GENE OVEREXPRESSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN INTERACTION; STIMULUS RESPONSE;

EID: 33846044082     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yexcr.2006.10.011     Document Type: Article

References (35)

1. Anneren C. J. Endocrinol. 172 (2002) 145-153
2. Anneren C., Lindholm C.K., Kriz V., and Welsh M. Curr. Mol. Med. 3 (2003) 313-324
3. Anneren C., Reedquist K.A., Bos J.L., and Welsh M. J. Biol. Chem. 275 (2000) 29153-29161
4. Barila D., and Superti-Furga G. Nat. Genet. 18 (1998) 280-282
5. Cardozo A.K., Ortis F., Storling J., Feng Y.M., Rasschaert J., Tonnesen M., Van Eylen F., Mandrup-Poulsen T., Herchuelz A., and Eizirik D.L. Diabetes 54 (2005) 452-461
6. Chartier C., Degryse E., Gantzer M., Dieterle A., Pavirani A., and Mehtali M. J. Virol. 70 (1996) 4805-4810
7. Cinato E., Mirotsou M., and Sablitzky F. Genesis 31 (2001) 118-125
8. Claesson-Welsh L., Welsh M., Ito N., Anand-Apte B., Soker S., Zetter B., O'Reilly M., and Folkman J. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 5579-5583
9. Dan S., Naito M., Seimiya H., Kizaki A., Mashima T., and Tsuruo T. Oncogene 18 (1999) 1277-1283
10. Dixelius J., Larsson H., Sasaki T., Holmqvist K., Lu L., Engstrom A., Timpl R., Welsh M., and Claesson-Welsh L. Blood 95 (2000) 3403-3411
11. Druker B.J., Tamura S., Buchdunger E., Ohno S., Segal G.M., Fanning S., Zimmermann J., and Lydon N.B. Nat. Med. 2 (1996) 561-566
12. Echarri A., and Pendergast A.M. Curr. Biol. 11 (2001) 1759-1765
13. Erpel T., Superti-Furga G., and Courtneidge S.A. EMBO J. 14 (1995) 963-975
14. Hagerkvist R., Mokhtari D., Myers J.W., Tengholm A., and Welsh N. Ann. N. Y. Acad. Sci. 1040 (2005) 114-122
15. Holmqvist K., Cross M.J., Rolny C., Hagerkvist R., Rahimi N., Matsumoto T., Claesson-Welsh L., and Welsh M. J. Biol. Chem. 279 (2004) 22267-22275
16. Igney F.H., and Krammer P.H. Nat. Rev., Cancer 2 (2002) 277-288
17. Ito Y., Pandey P., Mishra N., Kumar S., Narula N., Kharbanda S., Saxena S., and Kufe D. Mol. Cell. Biol. 21 (2001) 6233-6242
18. Karlsson T., and Welsh M. Oncogene 13 (1996) 955-961
19. Kumar S., Mishra N., Raina D., Saxena S., and Kufe D. Mol. Pharmacol. 63 (2003) 276-282
20. Lindholm C.K., Frantz J.D., Shoelson S.E., and Welsh M. Biochem. Biophys. Res. Commun. 278 (2000) 537-543
21. Lindholm C.K., Henriksson M.L., Hallberg B., and Welsh M. Eur. J. Biochem. 269 (2002) 3279-3288
22. Lowe S.W., Cepero E., and Evan G. Nature 432 (2004) 307-315
23. Lu L., Anneren C., Reedquist K.A., Bos J.L., and Welsh M. Exp. Cell Res. 259 (2000) 370-377
24. Lu L., Holmqvist K., Cross M., and Welsh M. Cell Growth Differ. 13 (2002) 141-148
25. Mostoslavsky G., Kotton D.N., Fabian A.J., Gray J.T., Lee J.S., and Mulligan R.C. Mol. Ther. 11 (2005) 932-940
26. Oda T., Kujovich J., Reis M., Newman B., and Druker B.J. Oncogene 15 (1997) 1255-1262
27. Raina D., Mishra N., Kumar S., Kharbanda S., Saxena S., and Kufe D. Mol. Pharmacol. 61 (2002) 1489-1495
28. Roumiantsev S., Shah N.P., Gorre M.E., Nicoll J., Brasher B.B., Sawyers C.L., and Van Etten R.A. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 10700-10705
29. Siddik Z.H. Oncogene 22 (2003) 7265-7279
30. Welsh M., Christmansson L., Karlsson T., Sandler S., and Welsh N. Mol. Med. 5 (1999) 169-180
31. Welsh M., Mares J., Karlsson T., Lavergne C., Breant B., and Claesson-Welsh L. Oncogene 9 (1994) 19-27
32. Welsh M., Songyang Z., Frantz J.D., Trub T., Reedquist K.A., Karlsson T., Miyazaki M., Cantley L.C., Band H., and Shoelson S.E. Oncogene 16 (1998) 891-901
33. Ventura A., Meissner A., Dillon C.P., McManus M., Sharp P.A., Van Parijs L., Jaenisch R., and Jacks T. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 10380-10385
34. Xu C., Bailly-Maitre B., and Reed J.C. J. Clin. Invest. 115 (2005) 2656-2664
35. Yuan Z.M., Huang Y., Whang Y., Sawyers C., Weichselbaum R., Kharbanda S., and Kufe D. Nature 382 (1996) 272-274